-
Iron deficiency (ID) is the most prevalent micronutrient deficiency worldwide, resulting in adverse health outcomes including anemia, impaired muscle function, poor immune function, delayed psychomotor development, and impaired cognitive performance in children in the short and long term (1-2).
ID has three progressive stages which include depletion of iron stores (ID), iron deficient erythropoiesis (IDE), and iron deficiency anemia (IDA). Available indicators in different stages contain serum ferritin (SF), soluble transferrin receptor (sTfR), zinc protoporphyrin, transferrin saturation, body iron stores, hemoglobin, reticulocyte hemoglobin, and hepcidin, etc. Each indicator has their own strengths and limitations. SF is the most recommended indicator for determining ID because it reflects a state of iron store in the body and researchers have established a cutoff for iron depletion by using SF (3-4).
In 2015–2017, China completed its fifth National Nutrition and Health Surveillance and monitored the iron status with large-scale samples. The primary objective of this study was to analyze the prevalence of ID among children aged 6–17 years in China in 2016–2017 to provide guidance to the development of appropriate intervention strategies.
Sampling of participants was based on the protocol for China Nutrition and Health Surveillance of Children and Lactating Women (2016–2017). The details were described in the introduction of China Nutrition and Health Surveys (1982–2017) (5). The blood samples in the serum separator tube were promptly centrifuged at 3,000 ×g for 15 minutes after venous blood collection and coagulation at room temperature, divided into aliquots of serum, and frozen at –80 ℃ for subsequent assays: SF and high-sensitivity C-reactive protein (hsCRP). SF was measured by electrochemiluminescence immunoassay on Roche Modular e601 automated analyzer; and hsCRP by Roche Tina-quant immunoturbidimetric assay on Hitachi 7600 automatic biochemical analyzer.
All analyses were conducted with SPSS (version 23.0, IBM Corp, Armonk, NY, USA). We log transformed SF to normalize the distribution because SF concentrations were positively skewed. SF distribution was described as geometric means (
$\overline x $ G) and 95% confidence interval (95% CI) as well as selected percentiles by age and sex subgroups. Concentrations of hsCRP higher than 5 mg/L was considered as the presence of a possible infection or inflammation. ID was defined by the World Health Organization (WHO) recommended standard as SF<15 ng/mL and the National Hygienic Standard WS/T 465-2015 in China as SF<25 ng/mL; both standards were set in the absence of signs of inflammation (3,6). Independent t-tests and chi-squared tests were conducted on continuous variables and categorical variables between subgroups, respectively. Means, percentiles, ID prevalence, and differences between subgroups were analyzed from the method of complex sampling survey. The level of statistical significance was set at P<0.05.In total, 65,293 participants were included after exclusion of hsCRP>5 mg/L, with 32,503 (50.0%) being male and 32,790 (50.0%) being female. The age of all children ranged from 6 to <18 years old with a median age of 11.3 years. The study population distribution was presented in Table 1.
Age group (years) Total Urban Rural n $\bar{{{x}}}$G 95% CI n ${\bar{{x}}}$G 95% CI n $\bar{{{x}}}$G 95% CI 6–17 Total 65,293 56.6 56.0–57.2 30,960 57.9 57.0–58.8 34,333 55.5§ 54.7–56.2 Male 32,503 66.4 65.5–67.2 15,404 69.4 68.0–70.7 17,099 63.8§ 62.8–64.9 Female 32,790 47.3* 46.5–48.0 15,556 47.2* 46.1–48.4 17,234 47.3* 46.3–48.2 6–11 Subtotal 36,596 60.4 59.8–61.1 17,423 62.0 60.9–63.1 19,173 59.3§ 58.5–60.2 Male 18,223 60.5 59.6–61.5 8,665 62.2 60.7–63.8 9,558 59.3§ 58.1–60.6 Female 18,373 60.3 59.4–61.3 8,758 61.7 60.2–63.3 9,615 59.3§ 58.2–60.5 12–17 Subtotal 28,697 53.1 52.2–54.0 13,537 54.8 53.5–56.2 15,160 51.3§ 50.2–52.5 Male 14,280 72.7† 71.3–74.2 6,739 75.8† 73.7–78.1 7,541 69.6†§ 67.8–71.4 Female 14,417 37.6*† 36.7–38.6 6,798 38.5*† 37.2–40.0 7,619 36.7*b§ 35.5–37.9 Abbreviation: CI=Confidence Interval; $\overline x $G=geometric means.
* P-value <0.05 for differences between male and female at same age group.
† P-value <0.05 for differences between children 6–11 years and 12–17 years.
§ P-value <0.05 for differences between urban and rural areas.Table 1. Serum ferritin levels for children aged 6–17 years — China, 2016–2017 (ng/mL).
As presented in Table 1, geometric mean SF concentrations were 57.9 (95% CI: 57.0–58.8) ng/mL and 55.5 (95% CI: 54.7–56.2) ng/mL for children aged 6–17 years in urban and rural areas, respectively. The SF concentrations were significantly higher in urban than those in rural areas, while males had a higher levels than that of females (P<0.05). The ferritin concentration in female subgroup aged 12–17 years was the lowest among all the subgroups (P<0.05).
Table 2 described the percentile distribution of SF concentrations in age and sex subgroups, which were widely arranged and varied among subgroups.
Age group (years) P2.5 P5 P10 P25 P50 P75 P90 P95 P97.5 Total 6–17 Total 9.8 15.2 23.4 38.7 59.9 89.6 131.8 166.3 203.9 Male 17.9 23.1 30.3 45.0 66.5 100.3 147.7 188.3 225.7 Female 7.0 10.3 16.9 32.2 52.5 79.2 112.4 137.3 165.4 6–11 Subtotal 19.1 24.0 30.5 43.1 61.4 86.1 119.3 146.1 179.4 Male 19.3 24.1 30.5 43.3 61.2 84.9 119.7 148.2 187.8 Female 18.8 23.9 30.4 43.0 61.7 87.2 118.7 142.6 171.0 12–17 Subtotal 7.2 10.7 17.1 33.4 58.0 93.9 144.1 181.2 221.8 Male 16.7 21.8 30.1 47.6 75.1 118.2 171.5 212.7 251.8 Female 5.2 7.3 11.0 22.7 42.7 68.9 102.7 131.2 160.6 Urban 6–17 Total 9.2 14.5 22.5 38.3 61.4 95.5 141.0 181.0 220.7 Male 17.6 22.8 30.3 45.6 69.5 108.2 159.1 206.1 246.3 Female 6.5 9.7 15.6 31.2 52.7 81.4 118.6 146.2 177.8 6–11 Subtotal 18.2 23.4 30.0 43.3 63.1 90.8 125.9 158.7 197.5 Male 18.5 23.5 30.5 43.3 62.4 91.0 127.6 168.7 206.1 Female 17.8 23.3 29.6 43.2 63.6 90.8 125.0 153.3 189.1 12–17 Subtotal 7.0 10.7 17.2 33.7 59.6 100.1 152.3 193.5 236.1 Male 16.8 22.3 30.3 48.5 79.6 124.8 181.0 224.7 262.5 Female 5.2 7.1 11.2 22.9 43.5 71.4 111.6 142.0 170.4 Rural 6–17 Total 10.5 16.0 24.0 39.1 58.9 85.1 122.6 153.0 184.4 Male 18.1 23.4 30.3 44.4 64.3 93.1 138.3 172.9 205.2 Female 7.4 10.8 17.9 33.2 52.4 76.9 105.9 129.0 152.5 6–11 Subtotal 19.9 24.5 30.8 43.0 60.1 83.5 113.8 138.6 166.7 Male 20.1 24.5 30.5 43.3 60.1 81.9 114.4 140.5 168.9 Female 19.7 24.5 31.1 42.7 60.1 85.0 113.6 136.8 161.4 12–17 Subtotal 7.4 10.7 17.1 33.2 56.4 88.1 134.5 171.6 206.1 Male 16.3 21.4 29.8 46.7 71.6 109.6 161.1 198.4 231.6 Female 5.2 7.4 10.8 22.4 41.9 66.3 95.4 118.0 141.5 Table 2. Median and selected percentiles of serum ferritin concentrations for children aged 6–17 years in China in 2016–2017 (ng/mL).
The prevalence of ID for children was shown in Table 3. Overall, the prevalence of ID in children aged 6–17 years, as defined by SF<25 ng/mL and SF<15 ng/mL, was 11.2% and 4.9% in this weighted population, respectively. According to ID judged by the cut-off value of 25 or 15 ng/mL for SF concentration, the prevalence of ID was significantly different in the subgroups by age, sex, or regions (P<0.05). Children aged 12–17 years had a higher incidence of ID than children aged 6–11 years (P<0.05). Males had a lower ID prevalence than females (P<0.05). The prevalence of ID in urban areas was significantly different with that in rural areas (P<0.05).
Age group (years) SF<25 ng/mL SF<15 ng/mL Total Urban Rural Total Urban Rural 6–17 Total 11.2(10.8, 11.6) 11.8(11.2, 12.4) 10.6(10.1, 11.2)§ 4.9(4.6, 5.2) 5.4(4.9, 5.8) 4.5(4.1, 4.9)§ Male 6.1(5.7, 6.6) 6.3(5.7, 7.0) 5.9(5.4, 6.6) 1.6(1.4, 1.9) 1.8(1.5, 2.2) 1.4(1.2, 1.8) Female 16.9(16.2, 17.6)* 18.0(16.9, 19.0) * 16.0(15.0, 17.0)*§ 8.6(8.1, 9.2)* 9.3(8.5, 10.2)* 7.9(7.3, 8.7)*§ 6–11 Subtotal 5.5(5.1, 5.9) 6.0(5.4, 6.6) 5.2(4.6, 5.8) 1.3(1.1, 1.5) 1.5(1.3, 1.9) 1.1(0.8,1.4) Male 5.5(5.0, 6.1) 6.0(5.3, 6.8) 5.2(4.4, 6.1) 1.2(0.9, 1.5) 1.5(1.1, 2.0) 1.0(0.6, 1.5) Female 5.5(4.9, 6.2) 6.0(5.1, 7.0) 5.2(4.4, 6.1) 1.4(1.1, 1.7) 1.6(1.2, 2.2) 1.2(0.9, 1.6) 12–17 Subtotal 16.7(16.0, 17.4) 16.4(15.5, 17.4) 16.9(16.0, 17.9) 8.4(7.9, 8.9) 8.4(7.7, 9.1) 8.4(7.7, 9.2) Male 6.7(6.1, 7.4)† 6.6(5.7, 7.6) 6.9(6.0, 7.8)† 2.0(1.7, 2.4)† 2.0(1.6, 2.7) 2.0(1.6, 2.6)† Female 27.6(26.4, 28.8)*† 27.1(25.4, 28.8) *† 28.1(26.4, 29.8)*† 15.4(14.4, 16.4)*† 15.2(13.9, 16.7)*† 15.5(14.1, 17.0)*† Abbreviation: SF=serum ferritin.
* Chi-squared test P-value <0.05 for differences between male and female at same age group;
† Chi-squared test P-value <0.05 for differences between children 6–11 years and 12–17 years.
§ Chi-squared test P-value <0.05 for differences between urban and rural areas.Table 3. Iron deficiency prevalence for children aged 6–17 years — China, 2016–2017 [% (95% CI)].
HTML
Citation: |